309 related articles for article (PubMed ID: 35163662)
1. FKBP52 in Neuronal Signaling and Neurodegenerative Diseases: A Microtubule Story.
Chambraud B; Byrne C; Meduri G; Baulieu EE; Giustiniani J
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163662
[TBL] [Abstract][Full Text] [Related]
2. A role for FKBP52 in Tau protein function.
Chambraud B; Sardin E; Giustiniani J; Dounane O; Schumacher M; Goedert M; Baulieu EE
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2658-63. PubMed ID: 20133804
[TBL] [Abstract][Full Text] [Related]
3. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.
Giustiniani J; Guillemeau K; Dounane O; Sardin E; Huvent I; Schmitt A; Hamdane M; Buée L; Landrieu I; Lippens G; Baulieu EE; Chambraud B
FASEB J; 2015 Aug; 29(8):3171-81. PubMed ID: 25888602
[TBL] [Abstract][Full Text] [Related]
4. Isomerization and Oligomerization of Truncated and Mutated Tau Forms by FKBP52 are Independent Processes.
Kamah A; Cantrelle FX; Huvent I; Giustiniani J; Guillemeau K; Byrne C; Jacquot Y; Landrieu I; Baulieu EE; Smet C; Chambraud B; Lippens G
J Mol Biol; 2016 Mar; 428(6):1080-1090. PubMed ID: 26903089
[TBL] [Abstract][Full Text] [Related]
5. FKBP immunophilins and Alzheimer's disease: a chaperoned affair.
Cao W; Konsolaki M
J Biosci; 2011 Aug; 36(3):493-8. PubMed ID: 21799260
[TBL] [Abstract][Full Text] [Related]
6. FKBP52.
Davies TH; Sánchez ER
Int J Biochem Cell Biol; 2005 Jan; 37(1):42-7. PubMed ID: 15381148
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
[TBL] [Abstract][Full Text] [Related]
8. Structure of the N-terminal domain of human FKBP52.
Li P; Ding Y; Wu B; Shu C; Shen B; Rao Z
Acta Crystallogr D Biol Crystallogr; 2003 Jan; 59(Pt 1):16-22. PubMed ID: 12499534
[TBL] [Abstract][Full Text] [Related]
9. FK506-Binding Proteins and Their Diverse Functions.
Tong M; Jiang Y
Curr Mol Pharmacol; 2015; 9(1):48-65. PubMed ID: 25986568
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of FKBP family protein: evaluation, structure, and function in mammals and Drosophila melanogaster.
Ghartey-Kwansah G; Li Z; Feng R; Wang L; Zhou X; Chen FZ; Xu MM; Jones O; Mu Y; Chen S; Bryant J; Isaacs WB; Ma J; Xu X
BMC Dev Biol; 2018 Mar; 18(1):7. PubMed ID: 29587629
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation.
Deleersnijder A; Van Rompuy AS; Desender L; Pottel H; Buée L; Debyser Z; Baekelandt V; Gerard M
J Biol Chem; 2011 Jul; 286(30):26687-701. PubMed ID: 21652707
[TBL] [Abstract][Full Text] [Related]
12. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
13. The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation.
Chambraud B; Belabes H; Fontaine-Lenoir V; Fellous A; Baulieu EE
FASEB J; 2007 Sep; 21(11):2787-97. PubMed ID: 17435176
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl-prolyl isomerase FKBP52 controls chemotropic guidance of neuronal growth cones via regulation of TRPC1 channel opening.
Shim S; Yuan JP; Kim JY; Zeng W; Huang G; Milshteyn A; Kern D; Muallem S; Ming GL; Worley PF
Neuron; 2009 Nov; 64(4):471-83. PubMed ID: 19945390
[TBL] [Abstract][Full Text] [Related]
15. FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention.
Annett S; Moore G; Robson T
Pharmacol Ther; 2020 Nov; 215():107623. PubMed ID: 32622856
[TBL] [Abstract][Full Text] [Related]
16. Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain.
Galigniana MD; Harrell JM; Murphy PJ; Chinkers M; Radanyi C; Renoir JM; Zhang M; Pratt WB
Biochemistry; 2002 Nov; 41(46):13602-10. PubMed ID: 12427021
[TBL] [Abstract][Full Text] [Related]
17. Impact of FKBP52 on cell proliferation and hormone-dependent cancers.
Hanaki S; Shimada M
Cancer Sci; 2023 Jul; 114(7):2729-2738. PubMed ID: 37026526
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology.
Gerard M; Deleersnijder A; Daniëls V; Schreurs S; Munck S; Reumers V; Pottel H; Engelborghs Y; Van den Haute C; Taymans JM; Debyser Z; Baekelandt V
J Neurosci; 2010 Feb; 30(7):2454-63. PubMed ID: 20164329
[TBL] [Abstract][Full Text] [Related]
19. Caspase-cleaved Tau-D(421) is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons.
Meduri G; Guillemeau K; Dounane O; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE; Giustiniani J
Neurobiol Aging; 2016 Oct; 46():124-37. PubMed ID: 27479154
[TBL] [Abstract][Full Text] [Related]
20. Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts the interaction with FKBP12 and FKBP52.
Neye H
Regul Pept; 2001 Mar; 97(2-3):147-52. PubMed ID: 11164950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]